Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Beitler

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 21, 2022
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral BloodDavid C Qian, Bryan C Ulrich, Gang Peng, et al.
Cancer|August 9, 2014
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neckNabil F Saba, Selwyn J Hurwitz, Kelly Magliocca, et al.
Oral Oncology|March 9, 2019
A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neckMatthew C Ward, Nancy Y Lee, Jimmy J Caudell, et al.
Head & Neck|March 29, 2021
Contemporary management of the neck in nasopharyngeal carcinomaWai Tong Ng, Raymond K Y Tsang, Jonathan J Beitler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2013
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic studyNabil F Saba, Selwyn J Hurwitz, Scott A Kono, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal CancerNabil F Saba, Seth Force, Charley Staley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2021
Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck CancerCanhua Xiao, Andrew H Miller, Gang Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2013
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studiesDong M Shin, Hongzheng Zhang, Nabil F Saba, et al.
International Journal of Radiation Oncology, Biology, Physics|December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck CancerJimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
International Journal of Radiation Oncology, Biology, Physics|November 21, 2022
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral BloodDavid C Qian, Bryan C Ulrich, Gang Peng, et al.
Cancer|August 9, 2014
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neckNabil F Saba, Selwyn J Hurwitz, Kelly Magliocca, et al.
Oral Oncology|March 9, 2019
A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neckMatthew C Ward, Nancy Y Lee, Jimmy J Caudell, et al.
Head & Neck|March 29, 2021
Contemporary management of the neck in nasopharyngeal carcinomaWai Tong Ng, Raymond K Y Tsang, Jonathan J Beitler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2013
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic studyNabil F Saba, Selwyn J Hurwitz, Scott A Kono, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal CancerNabil F Saba, Seth Force, Charley Staley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2021
Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck CancerCanhua Xiao, Andrew H Miller, Gang Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2013
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studiesDong M Shin, Hongzheng Zhang, Nabil F Saba, et al.
International Journal of Radiation Oncology, Biology, Physics|December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck CancerJimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.
Pageof 18